Subscribe to RSS
DOI: 10.1055/s-0040-1718417
Coronavirus Disease 2019 Infection among Children: Pathogenesis, Treatment, and Outcome
Funding None.

Abstract
Coronavirus disease 2019 (COVID-19) is a contagious disease that may lead to respiratory distress syndrome and even death. Neonates and children are most vulnerable population to COVID-19 infection; however, the infection is usually milder and has a better prognosis in pediatric patients compared with adults. It remains unclear why pediatric population is less symptomatic than adults. Children frequently experience respiratory infections and their immune system is in developing stage. However, large proportion of the asymptomatic pediatric population may contribute to transmission. This review explored several aspects of COVID-19 infection such as its epidemiology, its molecular pathogenesis with respect to angiotensin-converting enzyme 2 receptor and inflammatory mediators, intrauterine vertical transmission, imaging findings, and complications like cytokine release syndrome (multisystem inflammatory syndrome in children). We also looked at prognostic factors and treatment modalities like corticosteroids, RNA replicate inhibitors, protease inhibitors, Bruton tyrosine kinase inhibitor, that is, acalabrutinib and convalescent plasma therapy. Since there is no strong evidence for the intrauterine transmission, early isolation should be performed to protect a neonate from a COVID-19 infected mother. Development of vaccine and an effective antiviral drug are the need of the hour.
Publication History
Received: 22 June 2020
Accepted: 02 September 2020
Article published online:
05 October 2020
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of COVID-19 - studies needed. N Engl J Med 2020; 382 (13) 1194-1196
- 2 Wong SH, Lui RN, Sung JJ. COVID-19 and the digestive system. J Gastroenterol Hepatol 2020; 35 (05) 744-748
- 3 Wang T, Du Z, Zhu F. et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet 2020; 395 (10228): e52
- 4 Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). Treasure Island, FL: Statpearls Publishing; 2020
- 5 Duan YN, Zhu YQ, Tang LL, Qin J. CT features of novel coronavirus pneumonia (COVID-19) in children. Eur Radiol 2020; 30 (08) 4427-4433
- 6 Dong Y, Mo X, Hu Y. et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020; 145 (06) e20200702
- 7 The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) -China, 2020. China CDC Weekly 2020; 2 (08) 113-122
- 8 Guan WJ, Ni ZY, Hu Y. China Medical Treatment Expert Group for Covid-19. et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
- 9 Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J 2020; 39 (05) 355-368
- 10 Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020; 94 (07) e00127-e20
- 11 Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J 2020; 55 (04) 2000607
- 12 Li G, He X, Zhang L. et al. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19. J Autoimmun 2020; 112: 102463
- 13 Dashraath P, Wong JLJ, Lim MXK. et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020; 222 (06) 521-531
- 14 Chen H, Guo J, Wang C. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395 (10226): 809-815
- 15 Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med 2020; 144 (07) 799-805
- 16
Zhou P,
Yang XL,
Wang XG.
et al.
A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature
2020; 579 (7798): 270-273
MissingFormLabel
- 17 Wang S, Guo L, Chen L. et al. A case report of neonatal 2019 coronavirus disease in China. Clin Infect Dis 2020; 71 (15) 853-857
- 18 Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID-19 during pregnancy and possible vertical transmission. Am J Perinatol 2020; 37 (08) 861-865
- 19 Zeng H, Xu C, Fan J. et al. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA 2020; 323 (18) 1848-1849
- 20 Chen S, Huang B, Luo DJ. et al. [Pregnancy with new coronavirus infection: clinical characteristics and placental pathological analysis of three cases]. Zhonghua Bing Li Xue Za Zhi 2020; 49 (05) 418-423
- 21
Li M,
Chen L,
Zhang J,
Xiong C,
Li X.
The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs
by single-cell transcriptome study. PLoS One 2020; 15 (04) e0230295
MissingFormLabel
- 22 Wrapp D, Wang N, Corbett KS. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020; 367 (6483): 1260-1263
- 23 Celik O, Saglam A, Baysal B. et al. Factors preventing materno-fetal transmission of SARS-CoV-2. Placenta 2020; 97: 1-5
- 24 Chandrasekharan P, Vento M, Trevisanuto D. et al. Neonatal resuscitation and postresuscitation care of infants born to mothers with suspected or confirmed SARS-CoV-2 Infection. Am J Perinatol 2020; 37 (08) 813-824
- 25 Xing YH, Ni W, Wu Q. et al. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019. J Microbiol Immunol Infect 2020; 53 (03) 473-480
- 26 Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol 2017; 17 (08) 469-482
- 27 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506
- 28 Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G, Liao AH. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol 2020; 139: 103122
- 29 Liguoro I, Pilotto C, Bonanni M. et al. SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr 2020; 179 (07) 1029-1046
- 30
Garazzino S,
Montagnani C,
Donà D.
Italian SITIP-SIP Pediatric Infection Study Group,
Italian SITIP-SIP SARS-CoV-2 Paediatric Infection Study Group*.
et al.
Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary
data as at 10 April 2020. Euro Surveill 2020; 25 (18) 2000600
MissingFormLabel
- 31 Lorenz N, Treptow A, Schmidt S. et al. Neonatal early-onset infection with SARS-CoV-2 in a newborn presenting with encephalitic symptoms. Pediatr Infect Dis J 2020; 39 (08) e212
- 32 Chacón-Aguilar R, Osorio-Cámara JM, Sanjurjo-Jimenez I, González-González C, López-Carnero J, Pérez-Moneo-Agapito B. COVID-19: fever syndrome and neurological symptoms in a neonate. An Pediatr (Engl Ed) 2020; ; Jun; 92 (06) 373-374
- 33 Sinelli M, Paterlini G, Citterio M, Di Marco A, Fedeli T, Ventura ML. Early neonatal SARS-CoV-2 infection manifesting with hypoxemia requiring respiratory support. Pediatrics 2020; 146 (01) e20201121
- 34 Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults. Pediatr Pulmonol 2020; 55 (05) 1169-1174
- 35 DeBiasi RL, Song X, Delaney M. et al. Severe COVID-19 in children and young adults in the Washington, DC Metropolitan Region. J Pediatr 2020; 223: 199-203.e1
- 36
Garazzino S,
Montagnani C,
Donà D.
Italian SITIP-SIP Pediatric Infection Study Group,
Italian SITIP-SIP SARS-CoV-2 Paediatric Infection Study Group*.
et al.
Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary
data as at 10 April 2020. Euro Surveill 2020; 25 (18) 2000600
MissingFormLabel
- 37 Zhu H, Wang L, Fang C. et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020; 9 (01) 51-60
- 38 Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect 2020; 80 (06) 607-613
- 39 Pain CE, Felsenstein S, Cleary G. et al. Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms. Lancet Rheumatol 2020; 2 (07) e376-e379
- 40
New York State.
Governor Cuomo announces state is helping to develop the national criteria for identifying
and responding to COVID-related illness in children. Accessed September 1, 2020 at:
https://www.governor.ny.gov/news/governor-cuomo-announces-state-helping-develop-national-criteria-identifying-and-responding
MissingFormLabel
- 41
Paediatric Intensive Care Society.
PICS statement: increased number of reported cases of novel presentation of multisystem
inflammatory disease. Accessed April 27, 2020 at: https://pccsociety.uk/news/pics-statement-regarding-novel-presentation-of-multi-system-inflammatory-disease/
MissingFormLabel
- 42 Mahase E. COVID-19: concerns grow over inflammatory syndrome emerging in children. BMJ 2020; 369: m1710
- 43
Daskalakis DC.
2020 health alert #13: pediatric multi-system inflammatory syndrome potentially associated
with COVID-19. Pediatric Intensive Care Society. PICS Statement: increased number
of reported cases of novel presentation of multi-system inflammatory disease. Accessed
April 27, 2020 at: https://picsociety.uk/wpcontent/uploads/2020/04/PICS-statement-re-novel-KD-C19-presentation-v2-27042020.pdf
MissingFormLabel
- 44 Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395 (10237): 1607-1608
- 45 Verdoni L, Mazza A, Gervasoni A. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395 (10239): 1771-1778
- 46 Belhadjer Z, Méot M, Bajolle F. et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation 2020; 142: 429-436
- 47 Gefen AM, Palumbo N, Nathan SK, Singer PS, Castellanos-Reyes LJ, Sethna CB. Pediatric COVID-19-associated rhabdomyolysis: a case report. Pediatr Nephrol 2020; 35 (08) 1517-1520
- 48 Liu D, Li L, Wu X. et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol 2020; 215 (01) 127-132
- 49
Di Mascio D,
Khalil A,
Saccone G.
et al.
Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy:
a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020; 2 (02) 100107
MissingFormLabel
- 50 Chen L, Li Q, Zheng D. et al. Clinical characteristics of pregnant women with COVID-19 in Wuhan, China. N Engl J Med 2020; 382 (25) e100
- 51 Baud D, Greub G, Favre G. et al. Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection. JAMA 2020; 323 (21) 2198-2200
- 52 Hantoushzadeh S, Shamshirsaz AA, Aleyasin A. et al. Maternal death due to COVID-19. Am J Obstet Gynecol 2020; 223 (01) 109.e1-109.e16
- 53 Li J, Wang Y, Zeng Y. et al. Critically ill pregnant patient with COVID-19 and neonatal death within two hours of birth. Int J Gynaecol Obstet 2020; 150 (01) 126-128
- 54 Aliji N, Aliu F. Oligohydramnion in COVID19. Eur J Obstet Gynecol Reprod Biol 2020; 249: 102
- 55 Lu X, Zhang L, Du H. Chinese Pediatric Novel Coronavirus Study Team. et al. SARS-CoV-2 Infection in Children. N Engl J Med 2020; 382 (17) 1663-1665
- 56 Bernheim A, Mei X, Huang M. et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology 2020; 295 (03) 200463
- 57 Li Y, Cao J, Zhang X, Liu G, Wu X, Wu B. Chest CT imaging characteristics of COVID-19 pneumonia in preschool children: a retrospective study. BMC Pediatr 2020; 20 (01) 227
- 58 Feng K, Yun YX, Wang XF. et al. [Analysis of CT features of 15 Children with 2019 novel coronavirus infection]. Zhonghua Er Ke Za Zhi 2020; 58 (00) E007
- 59 Yu Y, Chen P. Coronavirus disease 2019 (COVID-19) in neonates and children from China: a review. Front Pediatr 2020; 8: 287
- 60 Jean SS, Lee PI, Hsueh PR. Treatment options for COVID-19: the reality and challenges. J Microbiol Immunol Infect 2020; 53 (03) 436-443
- 61 Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med 2006; 3 (09) e343
- 62 Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Shen Lim W. Corticosteroids as adjunctive therapy in the treatment of influenza: an updated cochrane systematic review and meta-analysis. Crit Care Med 2020; 48 (02) e98-e106
- 63 Arabi YM, Mandourah Y, Al-Hameed F. Saudi Critical Care Trial Group. et al. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med 2018; 197 (06) 757-767
- 64
World Health Organization.
Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV)
infection is suspected: interim guidance, 28 January 2020. Accessed March 13, 2020
at: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf
MissingFormLabel
- 65 Zhang J, Yang Y, Yang N. et al. Effectiveness of intravenous immunoglobulin for children with severe COVID-19: a rapid review. Ann Transl Med 2020; 8 (10) 625
- 66 Roschewski M, Lionakis MS, Sharman JP. et al. Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Sci Immunol 2020; 5 (48) 110
- 67 Dhama K, Sharun K, Tiwari R. et al. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccin Immunother 2020; 16 (06) 1232-1238
- 68 Ahn JY, Sohn Y, Lee SH. et al. Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea. J Korean Med Sci 2020; 35 (14) e149
- 69 Duan K, Liu B, Li C. et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA 2020; 117 (17) 9490-9496
- 70 Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci 2020; 10: 40
- 71 Li XY, Du B, Wang YS. et al. The keypoints in treatment of the critical coronavirus disease 2019 patient(2). Zhonghua Jie He He Hu Xi Za Zhi 2020; 43 (04) 277-281
- 72 Franchini M, Marano G, Velati C, Pati I, Pupella S, Maria Liumbruno G. Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy. Vox Sang 2020;
- 73 Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020; 58 (07) 1021-1028
- 74 Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta 2020; 507: 167-173
- 75 Henry BM, Benoit SW, de Oliveira MHS. et al. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): a pooled analysis and review. Clin Biochem 2020; 81: 1-8
- 76 Li H, Chen K, Liu M, Xu H, Xu Q. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia. J Infect 2020; 81 (01) 115-120